IN2013DN11328A - - Google Patents

Download PDF

Info

Publication number
IN2013DN11328A
IN2013DN11328A IN11328DEN2013A IN2013DN11328A IN 2013DN11328 A IN2013DN11328 A IN 2013DN11328A IN 11328DEN2013 A IN11328DEN2013 A IN 11328DEN2013A IN 2013DN11328 A IN2013DN11328 A IN 2013DN11328A
Authority
IN
India
Prior art keywords
turmerone
disorders
treatment
turmeric oil
abolene
Prior art date
Application number
Inventor
Witte Peter A M De
Camila V Esguerra
Alexander D Crawford
Paucar Adriana Monserrath Orellana
Original Assignee
Univ Leuven Kath
Univ De Cuenca
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leuven Kath, Univ De Cuenca filed Critical Univ Leuven Kath
Publication of IN2013DN11328A publication Critical patent/IN2013DN11328A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/121—Ketones acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to the anti Figure 2. convulsant activity of turmeric oil and its volatile bis- abolene sesquiterpenoids ar- turmerone, a-turmerone, b-turmerone (curlone) and a- atlantone, as an anticon B) vulsant agent for the treatment of epilepsy and/or as TURMERIC OIL therapeutic agents for the treatment of disorders of the central nervous system, including tremor, pain, mood 150000 disorders (including depression, bipolar disorder, atten tion deficit-hyperactivity disorder, and schizophrenia), and neurodegenerative diseases.
IN11328DEN2013 2011-07-04 2012-07-04 IN2013DN11328A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1111319.8A GB201111319D0 (en) 2011-07-04 2011-07-04 Anticonvulsant activity of tumeric oil and bisabolene sesquiterpenoids of curcuma longa
PCT/EP2012/063027 WO2013004740A1 (en) 2011-07-04 2012-07-04 Anticonvulsant activity of turmeric oil and bisabolene sesquiterpenoids

Publications (1)

Publication Number Publication Date
IN2013DN11328A true IN2013DN11328A (en) 2015-05-15

Family

ID=44512006

Family Applications (1)

Application Number Title Priority Date Filing Date
IN11328DEN2013 IN2013DN11328A (en) 2011-07-04 2012-07-04

Country Status (7)

Country Link
US (1) US9782361B2 (en)
EP (1) EP2729138B8 (en)
JP (1) JP6090867B2 (en)
ES (1) ES2661844T3 (en)
GB (1) GB201111319D0 (en)
IN (1) IN2013DN11328A (en)
WO (1) WO2013004740A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101517843B1 (en) 2013-09-30 2015-05-08 한국인스팜(주) A composition comprising an non-polar solvent soluble extract of Curcuma aromatica SALISB or ar-turmerone for preventing or treating a stress-involved disease
JP6773361B2 (en) * 2015-04-09 2020-10-21 ハウスウェルネスフーズ株式会社 Mood condition improver
JP6883845B2 (en) * 2017-03-17 2021-06-09 学校法人早稲田大学 Composition for promoting astrocyte differentiation
CN110721175A (en) * 2018-07-17 2020-01-24 文小燕 Application of curcuma extract in preparation of medicine for treating epilepsy
FR3098396B1 (en) * 2019-07-10 2022-07-29 Indigo Therapeutics Composition for the treatment of emotional disorders
CN113759007B (en) * 2020-08-25 2023-03-21 北京康仁堂药业有限公司 Quality control method of curcuma kwangsiensis

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100528149C (en) 2001-12-14 2009-08-19 科学与工业研究会 A composition for treating neurocerebrovascular disorders
US20040254146A1 (en) * 2002-05-21 2004-12-16 Nastech Pharmaceutical Company Inc. Carboxylate salts of galantamine and their pharmaceutical use
JP2004331539A (en) * 2003-05-06 2004-11-25 Maruzen Pharmaceut Co Ltd Hepatic disease-preventing and treating agent and hepatic disease-preventing and treating food or drink
AU2007227397A1 (en) 2006-03-17 2007-09-27 Herbalscience Singapore Pte. Ltd. Extracts and methods comprising curcuma species
CN101199833B (en) * 2007-12-21 2011-03-16 北京中科雍和医药技术有限公司 Compound essential oil of releasing arthritis ache
TW201019949A (en) 2008-10-16 2010-06-01 Herbalscience Group Llc Extracts of curcuma and methods of use thereof
SG178191A1 (en) 2009-07-31 2012-03-29 Cognition Therapeutics Inc Inhibitors of cognitive decline
EP2519137A1 (en) 2009-12-31 2012-11-07 Arçelik Anonim Sirketi A dishwasher comprising a microfilter
CA2793045A1 (en) * 2010-03-15 2011-09-22 Laila Nutraceuticals Boswellia oil, its fractions and compositions for enhancing brain function
EP3290045A1 (en) * 2010-04-05 2018-03-07 Benny Antony Formulation of curcumin with enhanced bioavailability of curcumin and method of preparation and treatment thereof

Also Published As

Publication number Publication date
EP2729138B8 (en) 2018-02-28
EP2729138A1 (en) 2014-05-14
GB201111319D0 (en) 2011-08-17
JP2014518241A (en) 2014-07-28
US9782361B2 (en) 2017-10-10
ES2661844T3 (en) 2018-04-04
EP2729138B1 (en) 2017-12-13
JP6090867B2 (en) 2017-03-08
US20140243420A1 (en) 2014-08-28
WO2013004740A1 (en) 2013-01-10

Similar Documents

Publication Publication Date Title
IN2013DN11328A (en)
CL2015000096A1 (en) Compounds derived from 4-methyl-2,3,5,9,9b-pentaaza-cyclopenta [a] naphthalenes, phosphodiestearase 2 and / or 10 inhibitors; pharmaceutical composition; and its use for prevention or treatment of diseases of the nervous system, such as cognitive deficiency, dementia, anxiety disorders, enf. from Alzheimer, enf. from parkinson, others
EA201590654A1 (en) COMBINATION OF RASAGILIN AND PRIDOPIDINE FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS, IN PARTICULAR OF HANTINGTON'S DISEASE
GB201111712D0 (en) Pharmaceutical compositions
AU2018247351B2 (en) Methods and compositions for treatment of demyelinating diseases
GEP20186928B (en) Binding molecules for bcma and cd3
MX2014002459A (en) Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof.
EA201590655A8 (en) COMBINATION OF LACHINIMODE AND PRIDOPIDINE FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS
PH12014502218A1 (en) Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
AU2012277802A8 (en) Novel inhibitor compounds of phosphodiesterase type 10A
TN2013000348A1 (en) Compounds and compositions as trk inhibitors
NZ773177A (en) Neuroactive steroid formulations and methods of treating cns disorders
MX356865B (en) New therapeutic approaches for treating parkinson's disease.
MY166890A (en) Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
AU2012286851A8 (en) Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
MX2012004078A (en) Compounds and compositions as modulators of gpr119 activity.
CY1118966T1 (en) NEW COMPOSITIONS FOR THE PREVENTION AND / OR TREATMENT OF CENTRAL NERVOUS SYSTEMS
UA109260C2 (en) CHROMON DERIVATIVES, METHODS OF THEIR PREPARATION AND THERAPEUTIC APPLICATIONS
CA2864606C (en) Methods of treating and preventing diseases and disorders of the central nervous system
EP2542085A4 (en) Compounds useful for treating neurodegenerative disorders
MX2021007142A (en) Organic compounds.
MX2014014066A (en) Chromane compounds.
WO2009151683A3 (en) Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications
MX343366B (en) Nd2 peptides and methods of treating neurological disease.
IN2014DN10081A (en)